KDM1A and melanoma: In addition, immunotherapy-resistant melanoma patients also express higher levels of phosphorylated S111 LSD1, similarly modulating stem-like EMT signatures and altering LSD1’s transcription regulation network in cancer-specific cells (42, 44).